Considering that IL-33 exerts its function by binding to its receptor ST2 on target cells, the expression of ST2 and sST2 or the ratio of ST2/sST2 will be a critical regulatory step for directing pro- and anti-tumor activity by IL-33. Here, IL33 is linked to neoplasm.